| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Statera Biopharma, Inc. | Director | Common Stock, par value $0.005 per share | 60,000 | 09 Sep 2021 | Direct | ||
| At Home Group Inc. | Director | Common Stock | 0 | $37.00 | 23 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000143774921023900-barbarick-steve-k-2021-09-09 | Statera Biopharma, Inc. | 09 Sep 2021 | 1 | $0 | 4 | Director | 19 Oct 2021, 16:05 |
| /report/000143774921017946-barbarick-steve-k-2021-07-27 | Cytocom, Inc. | 27 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 21:30 |
| /report/000110465921099243-barbarick-steve-k-2021-07-22 | At Home Group Inc. | 22 Jul 2021 | 2 | -$1,482,442 | 4 | Director | 03 Aug 2021, 10:40 |